146 related articles for article (PubMed ID: 38146796)
1. Investigation of radiomics models for predicting biochemical recurrence of advanced prostate cancer on pretreatment MR ADC maps based on automatic image segmentation.
Wang H; Wang K; Ma S; Gao G; Wang X
J Appl Clin Med Phys; 2024 Apr; 25(4):e14244. PubMed ID: 38146796
[TBL] [Abstract][Full Text] [Related]
2. Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
Han C; Ma S; Liu X; Liu Y; Li C; Zhang Y; Zhang X; Wang X
J Magn Reson Imaging; 2021 Dec; 54(6):1892-1901. PubMed ID: 33682286
[TBL] [Abstract][Full Text] [Related]
3. Deep learning-based radiomics model from pretreatment ADC to predict biochemical recurrence in advanced prostate cancer.
Wang H; Wang K; Zhang Y; Chen Y; Zhang X; Wang X
Front Oncol; 2024; 14():1342104. PubMed ID: 38476369
[TBL] [Abstract][Full Text] [Related]
4. Predicting Model of Biochemical Recurrence of Prostate Carcinoma (PCa-BCR) Using MR Perfusion-Weighted Imaging-Based Radiomics.
An P; Lin Y; Hu Y; Qin P; Ye Y; Gu W; Li X; Song P; Feng G
Technol Cancer Res Treat; 2023; 22():15330338231166766. PubMed ID: 37016971
[TBL] [Abstract][Full Text] [Related]
5. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
[TBL] [Abstract][Full Text] [Related]
6. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
7. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment.
Liu X; Wang X; Zhang Y; Sun Z; Zhang X; Wang X
Abdom Radiol (NY); 2022 Sep; 47(9):3327-3337. PubMed ID: 35763053
[TBL] [Abstract][Full Text] [Related]
9. Peritumoral Radiomics Strategy Based on Ensemble Learning for the Prediction of Gleason Grade Group of Prostate Cancer.
Qiu Y; Liu YF; Shu X; Qiao XF; Ai GY; He XJ
Acad Radiol; 2023 Sep; 30 Suppl 1():S1-S13. PubMed ID: 37393175
[TBL] [Abstract][Full Text] [Related]
10. MRI-Derived Radiomics Model to Predict the Biochemical Recurrence of Prostate Cancer Following Seed Brachytherapy.
Zhu X; Liu Z; He J; Li Z; Huang Y; Lu J
Arch Esp Urol; 2023 Jun; 76(4):264-269. PubMed ID: 37455525
[TBL] [Abstract][Full Text] [Related]
11. Predicting prostate cancer in men with PSA levels of 4-10 ng/mL: MRI-based radiomics can help junior radiologists improve the diagnostic performance.
Zhong JG; Shi L; Liu J; Cao F; Ma YQ; Zhang Y
Sci Rep; 2023 Mar; 13(1):4846. PubMed ID: 36964192
[TBL] [Abstract][Full Text] [Related]
12. A deep learning masked segmentation alternative to manual segmentation in biparametric MRI prostate cancer radiomics.
Bleker J; Kwee TC; Rouw D; Roest C; Borstlap J; de Jong IJ; Dierckx RAJO; Huisman H; Yakar D
Eur Radiol; 2022 Sep; 32(9):6526-6535. PubMed ID: 35420303
[TBL] [Abstract][Full Text] [Related]
13. Contrast-Enhanced Ultrasound-Magnetic Resonance Imaging Radiomics Based Model for Predicting the Biochemical Recurrence of Prostate Cancer: A Feasibility Study.
Wang Y; Feng G; Wang J; An P; Duan P; Hu Y; Ye Y; Li Y; Qin P; Song P
Comput Math Methods Med; 2022; 2022():8090529. PubMed ID: 35529273
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pelvic lymph node metastasis in prostate cancer using radiomics based on T
Liu X; Zhang Y; Sun Z; Wang X; Zhang X; Wang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1025-1036. PubMed ID: 36097770
[TBL] [Abstract][Full Text] [Related]
15. A dynamic-static combination model based on radiomics features for prostate cancer using multiparametric MRI.
Li S; Zheng T; Fan Z; Qu H; Wang J; Bi J; Lv Q; Zhang G; Cui X; Zhao Y
Phys Med Biol; 2022 Dec; 68(1):. PubMed ID: 36541844
[No Abstract] [Full Text] [Related]
16. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
[TBL] [Abstract][Full Text] [Related]
17. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
18. MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies.
Zhang L; Zhang J; Tang M; Lei XY; Li LC
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553012
[TBL] [Abstract][Full Text] [Related]
19. The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy.
Hu C; Qiao X; Hu C; Cao C; Wang X; Bao J
Cancer Imaging; 2024 Feb; 24(1):23. PubMed ID: 38326860
[TBL] [Abstract][Full Text] [Related]
20. Predicting biochemical recurrence in patients with high-risk prostate cancer using the apparent diffusion coefficient of magnetic resonance imaging.
Yoon MY; Park J; Cho JY; Jeong CW; Ku JH; Kim HH; Kwak C
Investig Clin Urol; 2017 Jan; 58(1):12-19. PubMed ID: 28097263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
